Micron Technology, Inc. (NASDAQ:MU) shares fell -3.
bluebird bio Inc (NASDAQ:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies, …
bluebird bio Inc (NASDAQ:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based …
BMO Capital analyst Jim Birchenough weighed in with a few insights on bluebird bio Inc (NASDAQ:BLUE) after the company announced that the NIH’s Recombinant DNA …
CTI BioPharma Corp (NASDAQ:CTIC) shares increased 9.6% to $2.
Maxim Group analyst Jason McCarthy weighed in today with a few insights on bluebird bio Inc (NASDAQ:BLUE), after the company made amendments on its …
In research report issued today, J.P.
In a research report issued today, Maxim Group analyst Jason Mccarthy maintained a Buy rating on bluebird bio Inc (NASDAQ:BLUE) with a price …
In a research report issued today, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on bluebird bio Inc (NASDAQ:BLUE), and raised the …
